William Nowatzke

William Nowatzke is a seasoned professional in the field of clinical laboratories and bioanalytical science, currently serving as Senior Director at Immunovant since March 2023. Prior to this role, William held significant positions such as Associate Director at Surrozen, where responsibilities included providing bioanalytical support for drug development programs, and Vice President of Biomarker Research & CLIA Laboratory Director at B2S Life Sciences, where William led the establishment of a CLIA-regulated laboratory and developed biomarker assays. With extensive experience in laboratory operations and management, William has previously served in leadership roles at organizations including Radix BioSolutions, Worldwide Clinical Trials, Biomimetic Therapeutics, Amgen, and LINCO Diagnostics. Educational credentials include a PhD in Biochemistry from Indiana University Bloomington and a DABCC in Clinical Chemistry from Washington University School of Medicine.